Literature DB >> 10076558

Two germline missense mutations at codons 804 and 806 of the RET proto-oncogene in the same allele in a patient with multiple endocrine neoplasia type 2B without codon 918 mutation.

A Miyauchi1, H Futami, N Hai, T Yokozawa, K Kuma, N Aoki, S Kosugi, K Sugano, K Yamaguchi.   

Abstract

Multiple endocrine neoplasia (MEN) type 2B is a clinically distinct entity among the autosomal dominant MEN 2 syndromes. Most patients with MEN 2B carry a germline mutation (M918T) of the RET proto-oncogene, while a few carry A883F. We examined a patient with MEN 2B, but without M918T or A883F, and her relatives. Here, we report the presence in this patient of 2 germline mutations, V804M and Y806C in the same allele. While the novel Y806C was inherited from her father, its carriers (her father and brother) was not affected by MEN 2. In contrast, V804M was a de novo mutation, that has been reported in patients with familial medullary thyroid carcinoma. Combinations of mutations of the RET proto-oncogene may cause oncogenic activities different from those of single mutations.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10076558      PMCID: PMC5925979          DOI: 10.1111/j.1349-7006.1999.tb00658.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  20 in total

1.  Germline and somatic mutations of the RET proto-oncogene in apparently sporadic medullary thyroid carcinomas.

Authors:  C Scurini; L Quadro; O Fattoruso; U Verga; A Libroia; G Lupoli; E Cascone; L Marzano; S Paracchi; B Busnardo; M E Girelli; A Bellastella; V Colantuoni
Journal:  Mol Cell Endocrinol       Date:  1998-02       Impact factor: 4.102

2.  Germline mutation of RET codon 883 in two cases of de novo MEN 2B.

Authors:  D P Smith; C Houghton; B A Ponder
Journal:  Oncogene       Date:  1997-09-04       Impact factor: 9.867

Review 3.  Genetic basis of endocrine disease: multiple endocrine neoplasia type 2.

Authors:  L M Mulligan; B A Ponder
Journal:  J Clin Endocrinol Metab       Date:  1995-07       Impact factor: 5.958

4.  Oncogenic activation of RET by two distinct FMTC mutations affecting the tyrosine kinase domain.

Authors:  A Pasini; O Geneste; P Legrand; M Schlumberger; M Rossel; L Fournier; B B Rudkin; I Schuffenecker; G M Lenoir; M Billaud
Journal:  Oncogene       Date:  1997-07-24       Impact factor: 9.867

5.  A novel point mutation in the intracellular domain of the ret protooncogene in a family with medullary thyroid carcinoma.

Authors:  R M Hofstra; O Fattoruso; L Quadro; Y Wu; A Libroia; U Verga; V Colantuoni; C H Buys
Journal:  J Clin Endocrinol Metab       Date:  1997-12       Impact factor: 5.958

6.  Genotype-phenotype correlation in multiple endocrine neoplasia type 2: report of the International RET Mutation Consortium.

Authors:  L M Mulligan; D J Marsh; B G Robinson; I Schuffenecker; J Zedenius; C J Lips; R F Gagel; S I Takai; W W Noll; M Fink
Journal:  J Intern Med       Date:  1995-10       Impact factor: 8.989

7.  DNA polymorphisms and conditions for SSCP analysis of the 20 exons of the ret proto-oncogene.

Authors:  I Ceccherini; R M Hofstra; Y Luo; R P Stulp; V Barone; T Stelwagen; R Bocciardi; H Nijveen; A Bolino; M Seri
Journal:  Oncogene       Date:  1994-10       Impact factor: 9.867

8.  Germline dinucleotide mutation in codon 883 of the RET proto-oncogene in multiple endocrine neoplasia type 2B without codon 918 mutation.

Authors:  O Gimm; D J Marsh; S D Andrew; A Frilling; P L Dahia; L M Mulligan; J D Zajac; B G Robinson; C Eng
Journal:  J Clin Endocrinol Metab       Date:  1997-11       Impact factor: 5.958

9.  Activation of RET as a dominant transforming gene by germline mutations of MEN2A and MEN2B.

Authors:  M Santoro; F Carlomagno; A Romano; D P Bottaro; N A Dathan; M Grieco; A Fusco; G Vecchio; B Matoskova; M H Kraus
Journal:  Science       Date:  1995-01-20       Impact factor: 47.728

10.  A novel somatic mutation in the RET proto-oncogene in familial medullary thyroid carcinoma with a germline codon 768 mutation.

Authors:  A Miyauchi; S Egawa; H Futami; K Kuma; T Obara; K Yamaguchi
Journal:  Jpn J Cancer Res       Date:  1997-06
View more
  35 in total

1.  Nine novel germline gene variants in the RET proto-oncogene identified in twelve unrelated cases.

Authors:  Syed A Ahmed; Karen Snow-Bailey; W Edward Highsmith; Weimin Sun; Raymond G Fenwick; Rong Mao
Journal:  J Mol Diagn       Date:  2005-05       Impact factor: 5.568

2.  RET proto-oncogene genotyping using unlabeled probes, the masking technique, and amplicon high-resolution melting analysis.

Authors:  Rebecca L Margraf; Rong Mao; W Edward Highsmith; Leonard M Holtegaard; Carl T Wittwer
Journal:  J Mol Diagn       Date:  2007-04       Impact factor: 5.568

3.  A Drosophila model of multiple endocrine neoplasia type 2.

Authors:  Renee D Read; Paul J Goodfellow; Elaine R Mardis; Nancy Novak; Jon R Armstrong; Ross L Cagan
Journal:  Genetics       Date:  2005-06-18       Impact factor: 4.562

Review 4.  Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma.

Authors:  Samuel A Wells; Sylvia L Asa; Henning Dralle; Rossella Elisei; Douglas B Evans; Robert F Gagel; Nancy Lee; Andreas Machens; Jeffrey F Moley; Furio Pacini; Friedhelm Raue; Karin Frank-Raue; Bruce Robinson; M Sara Rosenthal; Massimo Santoro; Martin Schlumberger; Manisha Shah; Steven G Waguespack
Journal:  Thyroid       Date:  2015-06       Impact factor: 6.568

Review 5.  Multiple Endocrine Neoplasia and Hyperparathyroid-Jaw Tumor Syndromes: Clinical Features, Genetics, and Surveillance Recommendations in Childhood.

Authors:  Jonathan D Wasserman; Gail E Tomlinson; Harriet Druker; Junne Kamihara; Wendy K Kohlmann; Christian P Kratz; Katherine L Nathanson; Kristian W Pajtler; Andreu Parareda; Surya P Rednam; Lisa J States; Anita Villani; Michael F Walsh; Kristin Zelley; Joshua D Schiffman
Journal:  Clin Cancer Res       Date:  2017-07-01       Impact factor: 12.531

Review 6.  Hereditary medullary thyroid carcinoma: the management dilemma.

Authors:  Ping Zhou; Jian Liu; Shao-Wen Cheng; Bing Wang; Rong Yang; Ling Peng
Journal:  Fam Cancer       Date:  2012-06       Impact factor: 2.375

Review 7.  Multiple endocrine neoplasia type 2.

Authors:  Mariola Peczkowska; Andrzej Januszewicz
Journal:  Fam Cancer       Date:  2005       Impact factor: 2.375

Review 8.  Genetics of the hamartomatous polyposis syndromes: a molecular review.

Authors:  Hui-Min Chen; Jing-Yuan Fang
Journal:  Int J Colorectal Dis       Date:  2009-04-21       Impact factor: 2.571

9.  Tandem Germline RET Mutations in a Family Pathogenetic for Multiple Endocrine Neoplasia 2B, Confirmed by a Natural Experiment.

Authors:  Minoru Kihara; Akira Miyauchi; Hiroshi Yoshida; Osamu Yamada; Hiroo Masuoka; Tomonori Yabuta; Takuya Higashiyama; Mitsuhiro Fukushima; Yasuhiro Ito; Kaoru Kobayashi; Akihiro Miya
Journal:  Eur Thyroid J       Date:  2014-12-03

10.  How to Assess the Clinical Relevance of Novel RET Missense Variants in the Absence of Functional Studies?

Authors:  Thomas Karrasch; Saskia M Herbst; Ute Hehr; Andreas Schmid; Andreas Schäffler
Journal:  Eur Thyroid J       Date:  2016-02-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.